A Phase II Study of SU011248 in Advanced Hepatocellular Carcinoma

Trial Profile

A Phase II Study of SU011248 in Advanced Hepatocellular Carcinoma

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Mar 2014

At a glance

  • Drugs Sunitinib (Primary)
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Apr 2008 Interim results were reported at AACR 2008 in the late-breaker session (abstract LB-139).
    • 02 Jan 2008 Status changed from recruiting to in progress.
    • 09 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top